{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-003429","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2026-07-07T20:30:21+00:00","discovered_at":"2026-07-07T20:31:01.315398+00:00","generated_at":"2026-07-07T20:31:13.977881+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeward issues $5.58M initial convertible notes; additional $5.58M contingent on milestones","bullets":["Initial $5.58M senior secured convertible notes at 8% interest, convertible at $5.40/share.","Additional $5.58M notes require 150% ReWalk unit sales growth or stock price ≥$13.80 for 10 days.","Warrants for 100% of conversion shares at $5.40 exercise price, 5-year term.","Beneficial ownership limited to 4.99%; exchange cap at 19.99% unless shareholder approval.","Oramed Pharmaceuticals acts as collateral agent for the transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-003429","json":"https://secwatch.observer/filing/0001178913-26-003429.json","markdown":"https://secwatch.observer/filing/0001178913-26-003429.md","text":"https://secwatch.observer/filing/0001178913-26-003429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/0001178913-26-003429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/zk2635657.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T20:31:13.977881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}